BioCentury | Feb 11, 2021
Product Development

Feb. 10 Quick Takes: Softly goes PacBio; plus PGDx, Nuvation Bio, Gamida, Portal Innovations

...and existing investors that participated included Northpond Ventures, Vensana Capital, Rock Springs Capital, Kern Capital, Sands Capital...
BioCentury | Jan 15, 2021
Product Development

Delfi and Earli series A rounds show there’s room for new entrants in early cancer detection

...publication. Joining Khosla Ventures in the $40 million round were Perceptive Advisors, Casdin Capital, Andreessen Horowitz, Sands Capital...
BioCentury | Jan 8, 2021
Finance

Jan. 8 Quick Takes: Venture rounds for Abbisko, DiCE, Aulos, LifeMine, Mana, Theolytics and more

...Management, Osage University Partners and Asymmetry Capital Management, as well as existing investors Northpond Ventures, Sands Capital...
BioCentury | Feb 20, 2020
Finance

With $88M series B, Spruce seeks short path to approval in rare endocrine disorder

...well as first-time backers HealthCap Partners, Rock Springs Capital, Citadel’s Surveyor Capital, Aisling Capital and Sands Capital...
BioCentury | Dec 17, 2019
Financial News

Dec. 17 Financial Quick Takes: Lilly sets 2020 guidance; plus JOINN, ArcherDX, KeChow, Aelis and ICT

...new backers Redmile Group, Soleus Capital, Driehaus Capital Management and ArrowMark Partners, plus existing investors Sands Capital...
BioCentury | Apr 26, 2019
Financial News

Schizophrenia therapy developer Karuna among four biotechs to file for IPOs

...investors Fidelity Management & Research Co., Eventide Asset Management, Pivotal bioVenture Partners, Partner Fund Management, Sands Capital...
BioCentury | Mar 18, 2019
Financial News

Karuna looks past schizophrenia with $68M series B

...included Fidelity Management & Research Co., Eventide Asset Management, Pivotal bioVenture Partners, Partner Fund Management, Sands Capital...
BioCentury | Dec 8, 2017
Financial News

Diagnostic company Qvella raises $20M in series B

...series B round led by existing investors RA Capital, Whitecap Venture Partners, Hatteras Venture and Sands Capital...
BioCentury | Dec 5, 2017
Financial News

Qvella raises $20M in series B

...series B round led by existing investors RA Capital, Whitecap Venture Partners, Hatteras Venture and Sands Capital...
BioCentury | Jun 23, 2017
Financial News

Avitide closes series E round

...June 21, biomanufacturing company Avitide Inc. (Lebanon, N.H.) closed a series E round led by Sands Capital...
Items per page:
1 - 10 of 18
BioCentury | Feb 11, 2021
Product Development

Feb. 10 Quick Takes: Softly goes PacBio; plus PGDx, Nuvation Bio, Gamida, Portal Innovations

...and existing investors that participated included Northpond Ventures, Vensana Capital, Rock Springs Capital, Kern Capital, Sands Capital...
BioCentury | Jan 15, 2021
Product Development

Delfi and Earli series A rounds show there’s room for new entrants in early cancer detection

...publication. Joining Khosla Ventures in the $40 million round were Perceptive Advisors, Casdin Capital, Andreessen Horowitz, Sands Capital...
BioCentury | Jan 8, 2021
Finance

Jan. 8 Quick Takes: Venture rounds for Abbisko, DiCE, Aulos, LifeMine, Mana, Theolytics and more

...Management, Osage University Partners and Asymmetry Capital Management, as well as existing investors Northpond Ventures, Sands Capital...
BioCentury | Feb 20, 2020
Finance

With $88M series B, Spruce seeks short path to approval in rare endocrine disorder

...well as first-time backers HealthCap Partners, Rock Springs Capital, Citadel’s Surveyor Capital, Aisling Capital and Sands Capital...
BioCentury | Dec 17, 2019
Financial News

Dec. 17 Financial Quick Takes: Lilly sets 2020 guidance; plus JOINN, ArcherDX, KeChow, Aelis and ICT

...new backers Redmile Group, Soleus Capital, Driehaus Capital Management and ArrowMark Partners, plus existing investors Sands Capital...
BioCentury | Apr 26, 2019
Financial News

Schizophrenia therapy developer Karuna among four biotechs to file for IPOs

...investors Fidelity Management & Research Co., Eventide Asset Management, Pivotal bioVenture Partners, Partner Fund Management, Sands Capital...
BioCentury | Mar 18, 2019
Financial News

Karuna looks past schizophrenia with $68M series B

...included Fidelity Management & Research Co., Eventide Asset Management, Pivotal bioVenture Partners, Partner Fund Management, Sands Capital...
BioCentury | Dec 8, 2017
Financial News

Diagnostic company Qvella raises $20M in series B

...series B round led by existing investors RA Capital, Whitecap Venture Partners, Hatteras Venture and Sands Capital...
BioCentury | Dec 5, 2017
Financial News

Qvella raises $20M in series B

...series B round led by existing investors RA Capital, Whitecap Venture Partners, Hatteras Venture and Sands Capital...
BioCentury | Jun 23, 2017
Financial News

Avitide closes series E round

...June 21, biomanufacturing company Avitide Inc. (Lebanon, N.H.) closed a series E round led by Sands Capital...
Items per page:
1 - 10 of 18